Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
2
×
boston blog main
boston top stories
life sciences
national blog main
allergan
brexanalone
clinical data
clinical trials
crispr
cynthia collins
depression
drugs
editas medicine
gene editing
jeff jonas
katrine bosley
leber congenital amaurosis
major depressive disorder
mental illness
national top stories
neuroscience
phase 3 trial
postpartum depression
psychiatric disorders
sage therapeutics
What
trial
2
×
allergan
approval
blessing
bosley
brexanalone
ceo
check
clinical
crispr
cusp
depart
depression
drug
editas
editing
experimental
fda
gene
hits
hour
humans
infusion
katrine
mark
medical
medicine
million
partner
phase
postpartum
ppd
regulatory
sage
soon
stock
supervised
surges
test
therapeutics
Language
Current search:
trial
×
boston
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Sage Hits Mark in Postpartum Depression Phase 3 Trial, Stock Surges
